U.S. Specialized REITs Stock News

CareTrust REIT (CTRE) is back in focus after raising its 2026 earnings guidance alongside second quarter results that included higher normalized funds from operations and record investment activity across skilled nursing, U.K. care homes and SHOP assets. See our latest analysis for CareTrust REIT. After the updated 2026 guidance and record second quarter investments, CareTrust REIT’s 1 month share price return of 2.49% and year to date share price return of 13.52% suggest constructive...

Everpure stock has delivered very strong gains over the past few years, while the valuation checks now send mixed signals. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, yet the earnings multiple view leans expensive and the overall value score is low. Everpure has returned 351.8% over 5 years, which puts current buyers squarely focused on whether that pace is already reflected in the price. The market's optimism around Everpure's ability to keep turning...

In early August 2026, Natera reported second-quarter revenue of US$752.75 million with higher testing volumes and narrower losses, raised full-year 2026 revenue guidance to US$2.85 billion–US$2.91 billion, and filed an US$849.22 million shelf registration for 3,200,000 common shares tied to an ESOP offering. At the same time, Natera moved to deepen Signatera’s role in oncology by seeking Japanese approval of the test as a companion diagnostic in muscle-invasive bladder cancer, extending its...

In the past quarter, XPO, Inc. reported second-quarter 2026 results with sales of US$2,355 million and net income of US$162 million, alongside completing a US$224.99 million share repurchase and adding industry veteran Michael Kneeland to its board. This combination of stronger earnings, ongoing buybacks, and added board expertise may influence how investors assess XPO’s operations and capital allocation. We’ll now examine how XPO’s higher quarterly earnings per share might reshape its...

In the second quarter of 2026, Lennox International reported higher sales of US$1,545.3 million but essentially flat diluted EPS, while also completing a large share repurchase program totaling 16.72 million shares for US$3.45 billion since its October 2014 authorization. The company’s decision to slightly lower full‑year 2026 EPS guidance to US$23.00–US$24.00, despite reaffirming about 8% revenue growth aided by acquisitions, highlights the pressure from weaker residential demand even as...

Hayward Holdings (HAYW) has caught investor attention after its late July 2026 update, which combined solid quarterly results, reaffirmed full year guidance, a completed debt refinancing, and an active share repurchase program. See our latest analysis for Hayward Holdings. Over the past year Hayward Holdings has seen a modest 1 year total shareholder return of 4.22%, while its 90 day share price return of 10.01% suggests momentum has picked up around the July earnings, refinancing, and...

Goldman Sachs Group (GS) has drawn fresh attention after a busy run of fixed income activity, including new callable senior notes across maturities from 2027 to 2041, alongside a reinsurance partnership with Talcott Financial Group. See our latest analysis for Goldman Sachs Group. At a share price of $1,039.61, Goldman Sachs Group has seen a 7 day share price return of 2.08% and a 90 day share price return of 10.03%, while the 1 year total shareholder return of 47.04% points to momentum that...

What Twilio’s latest earnings and guidance mean for shareholders Twilio (TWLO) has just released a packed second quarter update, combining strong headline results, fresh guidance and progress on its share buyback that together give investors more concrete data to work with. The company reported second quarter 2026 sales of US$1,499.09 million compared with US$1,228.43 million a year earlier, while net income was US$1,067.21 million compared with US$22.42 million. Basic earnings per share from...

Figma (FIG) is back in focus after its second quarter 2026 earnings on 5 August, where revenue outpaced expectations, full year guidance was raised, and heavy AI investment weighed on both margins and the share price. See our latest analysis for Figma. Despite the earnings beat and higher full year revenue guidance on 5 August, Figma’s share price has fallen 2.84% over the past day and 4.24% over the past week. The 30 day share price return of 10.33% and 90 day share price return of 16.16%...

Alkermes plc recently reported past second-quarter 2026 results, with revenue rising to US$496.01 million while net income fell sharply to US$0.50 million, and the company issued guidance calling for third-quarter 2026 revenue of US$450 million to US$470 million alongside an expected full-year 2026 GAAP net loss of US$95 million to US$115 million. At the same time, Alkermes paused buybacks after repurchasing 5.32% of its shares since 2024 and filed a US$311.11 million employee share plan...

First National Bank Alaska reported half-year 2026 results, posting net income of US$41.99 million, and in July its board declared a US$4.00 per-share cash dividend payable on September 15, 2026 to shareholders of record on September 1, 2026. This combination of solid profitability and continued cash returns to shareholders highlights the bank’s emphasis on income generation and capital return discipline. We will now examine how the affirmed US$4.00 dividend and recent earnings performance...

Concentra Group Holdings Parent, Inc. reported past second-quarter 2026 results with sales of US$606.03 million and net income of US$65.30 million, and raised its full-year 2026 outlook while also affirming a US$0.0625 per-share dividend and completing a share repurchase tranche. The company coupled this guidance increase with a planned CEO transition effective November 1, 2026, signaling leadership continuity as it integrates acquisitions and expands its occupational health footprint. With...

Why Viavi Solutions Stock Is Back In Focus After Fresh Guidance Viavi Solutions (VIAV) is drawing renewed attention after reporting fourth quarter and full year 2026 results, alongside earnings guidance for the first quarter of fiscal 2027 that points to higher expected revenue. The company reported fourth quarter sales of US$443.1 million and net income of US$32.7 million, and guided first quarter fiscal 2027 net revenue to a range of US$450 million to US$460 million. Management also pointed...

Uranium Energy stock snapshot after recent price move Uranium Energy (UEC) has drawn fresh attention after a recent daily gain of 4.6%, capping a 17.3% move over the past week and a 6.9% rise over the past month. That short term strength sits alongside a decline of 31.6% over the past 3 months and a year to date fall of 14.1%. The stock is near $11.26, inviting closer scrutiny from investors. See our latest analysis for Uranium Energy. For Uranium Energy, the recent 1 day share price return...

In August 2026, Icahn Enterprises reported second-quarter sales of US$3,081 million and revenue of US$2,975 million, alongside a net loss of US$348 million, and its board declared a US$0.50 quarterly distribution per depositary unit for holders of record on August 17, 2026, payable on or about September 23, 2026. The combination of higher year-on-year sales and revenue with a wider net loss, while maintaining a cash distribution, highlights the tension between Icahn Enterprises’ income...

In early August 2026, Recursion Pharmaceuticals reported Q2 2026 results showing revenue of US$7.67 million versus US$19.22 million a year earlier, with net loss narrowing to US$131.01 million and basic loss per share from continuing operations improving to US$0.25 from US$0.41. While sales and revenue weakened sharply year on year, the smaller net loss suggests Recursion is tightening cost controls even as it pushes forward with its AI-enabled drug discovery model. Against this backdrop of...

Boston Scientific (BSX) is under close watch after a series of voluntary Class II device recalls affecting FARADRIVE steerable sheaths and FARASTAR pulsed field ablation generators used in cardiac and vascular procedures worldwide. See our latest analysis for Boston Scientific. The Boston Scientific share price has climbed in the last month, with a 30 day share price return of 10.14% and a 7 day gain of 5.52%. However, momentum has faded over the past quarter, with a 90 day share price return...

Dividend affirmation and earnings update set the tone for Walker & Dunlop Walker & Dunlop (WD) affirmed a third quarter 2026 dividend of $0.68 per share and released second quarter results, giving investors fresh information on income potential and recent business performance. See our latest analysis for Walker & Dunlop. Those earnings and dividend updates landed after a tough stretch for Walker & Dunlop’s stock, with the share price down 11.55% over 30 days and 24.34% year to date,...

Becton Dickinson stock has delivered a 19.2% return over the past year, and the latest valuation work using a Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares may still trade below that estimate by around 24.4%. At the same time, broad valuation checks point to a more mixed picture and standard earnings multiples look closer to fair value than outright cheap. Becton Dickinson’s 19.2% one year gain puts recent shareholders in profit, which raises the question of how...

First Advantage stock has delivered a 73.8% return over the past three years, yet the valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a large discount while traditional market multiples lean the other way. First Advantage's 73.8% three year return shows the stock has already rewarded shareholders and raises the bar for any further upside to be justified by fundamentals. Stronger demand for its screening and digital identity services can...

Why Taiwan Semiconductor Manufacturing Stock Is Back in Focus Strong AI related chip demand and expectations for global semiconductor sales to reach about US$1.5t in 2026 have pushed Taiwan Semiconductor Manufacturing (NYSE:TSM) into the spotlight for many investors. The company is being discussed as a key beneficiary of this broad industry demand, with its foundry business positioned across high performance computing, smartphones, automotive and other end markets. See our latest analysis for...

In early August 2026, Willdan Group, Inc. reported second-quarter sales of US$231.03 million and net income of US$24.35 million, both higher than a year earlier, alongside record diluted earnings per share from continuing operations of US$1.58. Alongside these results, Willdan raised its 2026 financial targets, now aiming for full-year net revenue of US$415 million to US$430 million, supported by growing commercial and data center work and recent acquisitions. With record earnings and higher...

Crocs stock has delivered a strong 81.6% return over the past year, yet the latest valuation checks still point to the shares trading below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) model and market multiples. The 81.6% gain over the last 12 months suggests sentiment around Crocs has been positive, even with recent swings around company updates. Recent record revenue and changes to how marketplace sales are reported can support cash flow expectations, while a...

Camden Property Trust (CPT) has reshaped its portfolio after completing the sale of its California assets for US$1.625b, redirecting capital toward newer Sunbelt properties, share repurchases, and reaffirmed full year guidance. See our latest analysis for Camden Property Trust. Camden Property Trust's latest California sale and Sunbelt repositioning come after a steady 6.68% 90 day share price return and a 10.40% 1 year total shareholder return. The 5 year total shareholder return shows a...